跳至主要内容
临床试验/CTRI/2024/01/061729
CTRI/2024/01/061729尚未招募4 期

Evaluate the effect of Eyedrop Shigrupatra Arka in Simple Allergic Conjunctivitis- Randomised Controlled Clinical Trial

Dr Anjali Avinash Khose0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Patients presenting with simple allergic conjunctivitis with established signs and symptoms of itching, redness, oedema and watering with eosiniphilia will be subjected for detailed anterior segment examination using slit lamp biomicroscope for diagnosis
  • 2 Either gender and socioeconomic status

排除标准

  • 1 Patient suffering from other forms of allergic conjunctivitis like keratoconjunctivitis sicca, atropic keratoconjunctivitis, giant papillary conjunctivitis, drug or material senstivity, perennial allergic conjunctivitis etc.
  • 2 Patients having severe conditions of ocular surface disorders
  • 3 Patients having complicated eye diseases like Trachoma, Trichiasis, Steven Johnson syndrome, Synechiae etc will be excluded
  • 4 Patient suffering from bacterial, viral, chlamydial, parasitic and all other types of conjunctivitis (contagious & non contagious)
  • 5 Patients suffering from corneal ulcers, opacities, trauma, foreign bodies, OSD, etc
  • 6 Conjunctival epitheliopathies like Pterygium, Pseudo-pterygium, Tumours, Retention cysts
  • 7 Diagnosed cases of Glaucoma, retinopathies, optic neuritis, dry eye and who are under long term topical ocular drug therapies for any ophthalmic infective conditions
  • 8 Extremely debilitated patients, pregnant ladies those who are working with on- screen professions
  • 9 Specific systemic disorders like Renal pathologies, Uncontrolled Diabetes, Hypertension, and Hyperlipidaemia, Cardiovascular diseases, etc

研究者

发起方
Dr Anjali Avinash Khose

相似试验